QA: Anixa Biosciences Inc in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000715446_2013_Anixa_Biosciences_Inc.pdf

Logs

Graph

Absolute values for 0000715446, Anixa Biosciences Inc

  xvar xval
0 AssetsCurrent 922,019
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 10,290
3 remainder_Assets 4,728,367
4 LiabilitiesCurrent 1,822,459
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,866,262
9 ResearchAndDevelopmentExpense 2,211,506
10 remainder_Expenses 139,037
11 remainder_Revenues 947,085
12 remainder_NetIncome 16,921
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,660,676
1 Liabilities 1,822,459
2 Expenses 5,216,805
3 Revenues 947,085
4 StockholdersEquity 3,838,217
5 NetIncome -4,252,799
6 ComprehensiveNetIncome -4,252,799
7 BaseVar 6,831,973
8 EconomicCapitalRatiobeforeLimitedLiability 1.10
9 EconomicCapitalRatio 2.38

Edgar->Model Mapping

Feature Distribution

Change over Time